Is it necessary to have routine blood tests in patients treated with isotretinoin?

Journal of Dermatological Treatment

Volumn 17, Issue 4, 2006, Pages 214-216

  Ertam, Ilgen ^a   Alper, Sibel ^a   Unal, Idil ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acne; Adverse effects; Blood tests; Isotretinoin; Skin

Indexed keywords

CHOLESTEROL; ISOTRETINOIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACNE VULGARIS; ADOLESCENT; ADULT; ANXIETY; ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; CHEILITIS; CONTROLLED STUDY; DERMATITIS; DOSE RESPONSE; EPISTAXIS; FACE ERYTHEMA; FEMALE; HORDEOLUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKIN; XEROPHTHALMIA; XEROSIS;

ACNE VULGARIS; ADOLESCENT; ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; ISOTRETINOIN; KIDNEY FUNCTION TESTS; LIPIDS; LIVER FUNCTION TESTS; MALE; NEEDS ASSESSMENT; URINALYSIS;

EID: 33748679704     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630600838359     Document Type: Article

References (13)

1. Thevarajah S, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB Jr. Trends in prescription of acne medication in the US: Shift from antibiotic to non-antibiotic treatment. J Dermatolog Treat. 2005;16:224-8.
2. Tanghetti EA. Combination therapy is the standard of care. Cutis. 2005;76(2suppl):8-14.
3. Simpson NB, Cunliffe WJ. Disorders of sebaceous glands. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's textbook of dermatology. Vol 3. Oxford: Blackwell Publications; 2004. 43.1-43.75.
4. Coates P, Vyakrnam S, Ravenscroft JC, Stables GI, Cunliffe WJ, Leyden JJ, et al. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol. 2005;153:1126-36.
5. Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003;206:37-53.
6. Michaelsson G, Vahlquist A, Mobacken H, Hersle K, Landegren J, Ronnerfalt L, et al. Changes in laboratory variables induced by isotretinoin treatment of acne. Acta Derm Venereol. 1986;66:144-8.
7. La Place M. Acute depression from isotretinoin. Another case. J Eur Acad Dermatol Venereol. 2005;19:380-99.
8. Al-Mutairi N, Manchanda Y, Nour-Eldin O, Sultan A. Isotretinoin in acne vulgaris: A prospective analysis of 160 cases from Kuwait. J Drugs Dermatol. 2005;4:369-73.
9. Tallab T, Joharji H, Jazei M, Bahamdan K, Ibrahim K, Karkashan E. Isotretinoin therapy: Any need for laboratory assessment? West Afr J Med. 2004;23:273-5.
10. Baxter KF, Ling TC, Barth JH, Cunliffe WJ. Retrospective survey of serum lipids in patients receiving more than three courses of isotretinoin. J Dermatolog Treat. 2003;14:216-18.
11. Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: Is there really a need to perform routine laboratory tests? J Dermatolog Treat. 2001; 12:9-12.
12. Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology. 2002;204:232-5.
13. Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacother. 2003;37:1622-4.